Discharge Summary – education completed, home BP monitor, lab schedule
Encounter: 3 | Document: 7 | Date: 2025-06-07
Patient: Mason Rivers (Male, DOB 2016-11-08)
-------------------------------------------------------------------------------

Hospital Course
---------------
Uncomplicated post‑operative recovery with immediate graft function. Creatinine decreased from 6.8 pre‑op to 0.98 on POD4.
Pain well controlled on oral regimen. Tolerating regular diet; ambulating. Foley removed POD3 with good spontaneous voids.

Key Discharge Labs
------------------
Serum creatinine: 0.98 mg/dL
BUN: 16 mg/dL
Potassium: 4.2 mmol/L
CO₂: 23 mmol/L
Tacrolimus trough: 7.6 ng/mL (goal 8–10)
WBC: 8.9 x10^3/µL | Hgb: 10.2 g/dL | Platelets: 310 x10^3/µL
Urinalysis: no proteinuria, no hematuria

Discharge Medications
---------------------
Tacrolimus 2.0 mg PO BID (target trough 8–10 ng/mL)
Mycophenolate mofetil 500 mg PO BID (~600 mg/m²)
Prednisone 0.2 mg/kg PO daily (taper plan over 3–6 months)
Valganciclovir 450 mg PO daily (CMV D+/R+ prophylaxis; dose renally adjusted)
TMP‑SMX (sulfamethoxazole‑trimethoprim) 80 mg TMP PO daily (PJP prophylaxis; M‑W‑F after 1 month)
Nystatin oral suspension 5 mL swish and swallow QID (oral candidiasis prophylaxis)
Amlodipine 2.5 mg PO daily (hypertension)
Famotidine 10 mg PO BID (GI prophylaxis)
Cholecalciferol 1000 IU PO daily

Follow‑Up & Monitoring
----------------------
- Labs Mon/Thu for 2 weeks, then weekly.
- Clinic in 1 week.
- Daily home BP log; call for sustained BP > 120/80 or symptoms.
- Wound care reviewed; activity restrictions for 6 weeks.

Condition on Discharge
----------------------
Stable; parents demonstrate medication administration competency.
